Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

921
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
921
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

796
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
796

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dressing up a Magnetic Nanoparticle at Atomic Resolution: Molecular Simulation of Full Carrier Grafting by Self-Assembled Monolayers.

The journal of physical chemistry. B·2026
Same author

Dysregulated Intraocular Pressure in Acanthamoeba Keratitis: Clinical Associations, Therapy, and Prognosis.

Microorganisms·2026
Same authorSame journal

Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

Klinische Monatsblatter fur Augenheilkunde·2026
Same authorSame journal

Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

Klinische Monatsblatter fur Augenheilkunde·2026
Same author

Integration of Mechanical Testing, In Vivo Optical Coherence Elastography and Personalized Finite Element Modeling to Predict Geometrical Outcomes of Corneal Cross-Linking.

Annals of biomedical engineering·2026
Same author

Enhancing Corneal Donation Through Hospital Collaborations in Germany: A 21-Year Perspective.

Cornea·2026
Same journal

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

[Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

Klinische Monatsblatter fur Augenheilkunde·2026
See all related articles

Related Experiment Video

Updated: Nov 8, 2025

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

20.1K

[Crosslinking and Keratoconus].

Stefan J Lang, Philip Maier, Thomas Reinhard

    Klinische Monatsblatter Fur Augenheilkunde
    |April 19, 2021
    PubMed
    Summary
    This summary is machine-generated.

    Corneal crosslinking halts progressive keratoconus by strengthening the cornea with riboflavin and UV-A light. Newer methods offer faster treatment and reduced pain, expanding its use for various eye conditions.

    More Related Videos

    Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
    05:56

    Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

    Published on: April 3, 2016

    9.1K
    Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
    12:25

    Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

    Published on: January 6, 2018

    8.0K

    Related Experiment Videos

    Last Updated: Nov 8, 2025

    Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
    07:29

    Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

    Published on: November 12, 2015

    20.1K
    Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
    05:56

    Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

    Published on: April 3, 2016

    9.1K
    Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
    12:25

    Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

    Published on: January 6, 2018

    8.0K

    Area of Science:

    • Ophthalmology
    • Corneal Surgery
    • Biomedical Engineering

    Background:

    • Keratoconus is a progressive eye condition causing corneal thinning and protrusion.
    • Corneal crosslinking is an established treatment to halt keratoconus progression.
    • Standard protocol involves epithelial abrasion, riboflavin, and UV-A irradiation.

    Purpose of the Study:

    • To review the efficacy and advancements in corneal crosslinking.
    • To discuss expanded indications and potential risks of the procedure.
    • To highlight newer techniques like accelerated and transepithelial crosslinking.

    Main Methods:

    • Review of existing literature on corneal crosslinking.
    • Analysis of the Dresden protocol and its modifications.
    • Examination of accelerated and transepithelial crosslinking techniques.

    Main Results:

    • Corneal crosslinking is effective in halting keratoconus progression.
    • Accelerated crosslinking reduces treatment time.
    • Transepithelial crosslinking may decrease postoperative pain and recovery time.

    Conclusions:

    • Corneal crosslinking is a valuable treatment for progressive keratoconus.
    • Advancements are expanding its applications, including post-LASIK ectasia and infectious keratitis.
    • Potential risks include pain, haze, scarring, and endothelial cell damage.